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The objective of this study was to carry out the phytochemical screening of the ethyl acetate extract of Combretum 
punctatum var. squamosum and to investigate anti-inflammatory and anti-oxidant activities. The phytochemical investigation 
indicated the presence of flavonoids and steroids in the extract. Anti-inflammatory activity was studied by in vitro inhibition 
of albumin denaturation and HRBC membrane stabilization methods; in vivo cotton pellet induced granuloma and 
carrageenan-induced paw oedema studies. The anti-oxidant activity was studied by lipid peroxidation and DPPH radical 
scavenging activity assays.The ethyl acetate extract at different concentrations showed a significant percent inhibition of 
albumin denaturation and percent inhibition of haemolysis when compared with the standard. The extract at 200 and  
400 mg/kg b.w. significantly reduced cotton pellet granuloma (P <0.001) and carrageenan paw oedema (P <0.05) when 
compared with the standard in rats.The extract at different concentrations also showed a significant percent inhibition of 
lipid peroxidation and DPPH when compared with the standard.Thus, the result indicates that the ethyl acetate extract 
exhibited significantly good anti-inflammatory and anti-oxidant activities. 
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Introduction 
The search for drugs in nature to liberate diseases 
dates from the far past and plants have served as a 
valuable source of drugs ever since ancient times. The 
whole lot was based on little knowledge on either the 
causes for the illnesses or which plant and how it 
could be utilized as a cure during those times1. In 
recent times, herbal medicines were used to cure 
sickness based on the theory that plants contain 
natural substances that can improve health and ease 
illnesses2. These traditional plant medicines were used 
with no proper investigation on the constituents and 
thetherapeutic activities of the plants. Therefore, 
research on plants has been a focus all over the world 
until today3. 
Combretum punctatum var. squamosum (Roxb.Ex. 
G. Don), belonging to the family Combretaceae, 
locally known as ‘Leihruisen’ in Mizoram, is a 
deciduous climber found mainly in South-east Asian 
countries like India, Burma, Bangladesh, Bhutan, 
Nepal, Philippines, Thailand, Vietnam, and China4. 
Traditionally, the juice of the fresh leaves is applied 
to wounds and cuts to stop bleeding; the broths of 
boiled leaves are taken as medicine for diarrhoea  
and cholera5. However, there is no proper 
investigation of the plant on its phytoconstituents and 
pharmacological activity. This study aimed at 
phytochemical screening and the evaluation of anti-
inflammatory and antioxidant activity of the plant. 
 
Materials and Methods 
 
Collection of plant material 
The leaves of C. punctatum var. squamosum were 
collected from Khanpui village, Aizawl District, 
Mizoram, India during April 2018. The plant was 
identified by the Botanical Survey of India, Kolkata. 
A voucher specimen (IBTH-1) is being preserved in 
the Department of Pharmacy, RIPANS for further 
reference. The leaves were cleaned and dried under 
shade to remove moisture with occasional shifting  
and then powdered with a mechanical grinder.  
It was then subjected to successive extraction of 
phytoconstituents using Soxhlet apparatus.  
 
Extraction of phytoconstituents 
The dried powdered leaves of the plant were 
defatted with petroleum ether and the defatted 
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powdered material thus obtained was further extracted 
with chloroform and ethyl acetate in a Soxhlet 
apparatus. The extraction was carried out exhaustively 
and the solvents were recovered by simple distillation. 
The extract was concentrated and dried to yield free-
flowing powder. 
 
Phytochemical analysis 
Preliminary phytochemical analysis of the ethyl 
acetate extract of C. punctatum var. squamosum  
for the presence of phytochemical constituents  
like alkaloids, carbohydrates, glycosides, steroids, 
flavonoids, phenols, tannins, proteins and amino 
acids, fats, and fixed oil were qualitatively  
carried out6,7. 
 
Animal care and handling  
The animal care and handling were carried out 
according to the guidelines issued by the World 
Health Organization, Geneva, Switzerland and the 
Indian National Science Academy (INSA), New 
Delhi, India. Usually, 6 to 8 weeks old healthy Swiss 
albino rats of both sexes weighing 100-180 g were 
picked out from an inbred colony maintained under 
the controlled conditions of temperature (25±2°C), 
humidity (55-60%) and 12 hours of light and dark 
cycle, respectively. The animals were housed in a 
sterile polypropylene cage containing wood powder 
(procured locally) as bedding material. The animals 
had free access to standard rodent diet and water. All 
animal experiments were carried out according to 
NIH, USA and Indian National Science Academy, 
New Delhi, India guidelines, after getting the 
approval of the Institutional Animal Ethics 
Committee of RIPANS, Aizawl - IAEC/RIPANS/42, 
Mizoram, India. 
 
Acute toxicity test 
The acute toxicity study of all extracts was 
performed as per the Organization for Economic  
Co-operation and Development (OECD-425) 
guidelines. The animals fasted overnight before  
oral administration of ethyl acetate extract of  
C. punctatum var. squamosum (2000 mg/kg body 
weight b.w.) in a single dose. After the extract was 
administered, food was withheld for a further 3-4 
hours. One animal was dosed at the test dose. If the 
animal died, the main test was conducted to determine 
the LD50. But if the animal survived, four additional 
animals were dosed sequentially so that a total of five 
animals were tested. However, if three animals died, 
the limit test was terminated and the main test was 
performed. Animals were observed continuously 
during the first 30 minutes after dosing and observed 
periodically (with special attention given during the 
first 4 hours) for the next 24 hours and then daily 
thereafter, for 14 days. All observations were 
systematically recorded with individual records being 
maintained for each animal. Observations included 
changes in skin and fur, eyes and mucous membranes 
and behavioural pattern. Attention was given for 
observations of tremors, convulsions, salivation, 
diarrhoea, lethargy, sleep, coma and mortality. The 
LD50 is greater than 2000 mg/kg b.w. if three or more 
animals survived. The LD50 is less than the test dose 
(2000 mg/kg b.w.) when three or more animals die8. 
 
In-vitro antioxidant  activity study of ethyl  acetate extract  
 
Lipid peroxidation inhibition assay 
In this assay, a modified thiobarbituric acid-
reactive species (TBARS) was used to measure the 
lipid peroxide formed, and egg yolk homogenate was 
used as a lipid source9,10.  The reaction mixture 
contains egg homogenate (0.5 mL of 10% v/v) and 
0.1 mL of extract in a test tube and made up to 1 mL 
with distilled water. 0.05 mL of FeSO4 (0.07 M) was 
added to induce lipid peroxidation and incubated for 
30 minutes. Then 1.5 mL of 20% acetic acid (pH 
adjusted to 3.5 with NaOH) and 1.5 mL of 0.8% (w/v) 
thiobarbituric acid (TBA) in 1.1% sodium dodecyl 
sulphate and 0.05 mL 20% trichloroacetic acid (TCA) 
were added and the resulting mixture was vortexed 
and then heated at 95 °C for 60 minutes. It was 
cooled, and 5.0 mL of butan-1-ol was added to each 
tube and centrifuged at 3000 rpm for 10 minutes. The 
absorbance of the organic upper layer was measured 
at 532 nm. In this study -tocopherol was used as 
standard. The percentage of inhibition was calculated 
as follows: 
 Percentage inhibition = (Absorbance of Control− Absorbance of Extract)Absorbance of Control ⨯ 100 
 
Determination of 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical 
scavenging activity 
The antioxidant activity of C. punctatum var. 
squamosum and the standard were estimated based on 
the DPPH  free radical scavenging effect according to 
the method described by Blois (1958)11 with slight 
modifications12. In this study, butylatedhydroxy 
toluene (BHT) was used as a reference standard. 
Exactly 3 mL of the extract and standard prepared in 
various concentrations (0.1, 0.5, 1, 2, 3, 4, and  
5 μg/mL) was mixed with 0.5 mL of DPPH solution 
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(0.1 mM). The extract and standard were incubated 
for 30 minutes at 37°C. Absorbance was measured at 
517 nm using an ultraviolet-visible (UV-Vis) 
spectrophotometer. The percentage of scavenging 
effect of DPPH free radical was calculated using the 
following equation.  
 % DPPH radical scavenging =  (Absorbance of Control− Absorbance of Extract)Absorbance of Control ⨯ 100 
 
In-vitro anti-inflammatory activity study of ethyl acetate 
extract  
 
Inhibition of albumin denaturation 
The anti-inflammatory activity of ethyl acetate 
extract of C. punctatum var. squamosum was studied 
by using inhibition of albumin denaturation method 
according to Mizushima et al.13, and Sakat et al.14, 
with minor changes15. Diclofenac sodium was used as 
the reference standard. The reaction mixture consists 
of test extract and standard prepared in various 
concentrations (100, 200, 300, 400, and 500 μg/mL) 
and 1 % aqueous solution of bovine albumin fraction. 
The pH of the reaction mixture was adjusted using a 
small amount of 1N HCl. The sample extracts were 
incubated at 37ºC for 20 min and then heated to 51ºC 
for 20 min. After cooling the samples the turbidity 
was measured at 660 nm (UV-Visible 
Spectrophotometer). The percentage inhibition of 
protein denaturation was calculated as follows:  
 Percentage inhibition= Absorbance of Control−  Absorbance of TestAbsorbance of Control ⨯ 100 
 
HRBC membrane stabilization method 
The anti-inflammatory activity of ethyl acetate 
extract of C. punctatum var. squamosum was studied 
by using stabilization method of human red blood cell 
(HRBC) membrane by hypotonicity induced 
membrane lysis16,17. Blood was collected (2 mL) from 
healthy volunteers and was mixed with an equal 
volume of sterilized Alsevers solution (2% dextrose, 
0.8% sodium citrate, 0.5% citric acid and 0.42% NaCl 
in distilled water) and centrifuged at 3,000 rpm. The 
packed cells were washed with isosaline solution and 
a 10% v/v suspension was prepared with normal 
saline and kept at 4oC undisturbed before use. 
Different concentrations of ethyl acetate extract of  
C. punctatum var. squamosum in normal saline and 
diclofenac sodium as standard (50, 100, 200, 500 and 
1,000 µg/0.5 mL) and control (distilled water instead 
of hypo saline to produce 100% hemolysis) were 
separately mixed with 1 mL of phosphate buffer, 2 
mL of hyposaline and 0.5 mL of 10 % HRBC 
suspension was added. All the assay mixtures were 
incubated at 37oC for 30 minutes and centrifuged at 
3,000 rpm for 20 minutes and haemoglobin content of 
the supernatant solution was estimated 
spectrophotometrically at 560 nm. The percentage of 
HRBC membrane stabilization or protection was 
calculated by using the following formula 
 Percentage inhibition of haemolysis= Abs of Control−  Abs of TestAbs of Control ⨯ 100 
 
In vivo anti-inflammatory activity study 
 
Carrageenan induced inflammation 
Rats were divided into four groups of four animals 
in each group. The test groups received different 
doses of the ethyl acetate extract of C. punctatum var. 
squamosum (200 and 400 mg/kg b.w.), the standard 
group receives Diclofenac sodium (40 mg/kg b.w.) 
while the normal group received the vehicle and 
served as control and was not induced for paw 
oedema. Paw oedema was induced in the test and 
standard groups by injecting 0.1 mL of 1% w/v 
carrageenan suspended in 1% CMC into sub-planter 
tissues of the left hind paw of each rat. The paw 
thickness was measured before injecting the 
carrageenan and after 1, 2, 3, 4, 5, 6 hours using a 
vernier calliper. The anti-inflammatory activity was 
calculated as percent inhibition of oedema in the 
animals treated with extract under test in comparison 
to the carrageenan control group18,19.The percentage 
inhibition of oedema was calculated using the formula 
 % inhibition = To − TtTo ⨯ 100 
 
Where Tt is the thickness of the paw of rats given 
test extract at corresponding time and To is the paw 
thickness of rats of the control group at the same time. 
All the values were expressed as Mean±S.E.M. the 
results were analyzed statistically by one-way 
ANOVA followed by Dunett Multiple comparison 
test, P <0.001 was considered significant. 
 
Cotton pellet induced granuloma 
In this study, the anti-inflammatory effect was 
evaluated by cotton pellet granuloma model (sub-
acute) using the method adopted by D’Arcy (1960)20. 
Rats were divided into four groups of four animals in 
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each group. The test groups received different doses 
of the ethyl acetate extract of C. punctatum var. 
squamosum (200 and 400 mg/kg b.w.), the standard 
group receives Diclofenac sodium (40 mg/kg b.w.) 
while the normal group received the vehicle and 
served as control and cotton pellets were not induced. 
Under light ether anaesthesia by using blunted 
forceps, a subcutaneous tunnel was made and 
sterilized cotton pellets (10±0.5 mg) were implanted 
in the axilla and groin region of each animal in the 
test and standard groups. After recovering from 
anaesthesia, the animals were treated orally with 
vehicle control (saline 10 mL/kg), standard drug and 
test drug and were administered for seven consecutive 
days. On the eighth day, the animals were sacrificed 
by excessive anaesthesia and the cotton pellets were 
removed surgically. Pellets were separated from 
extraneous tissue and weighed immediately for wet 
weight and then dried at 60°C until the weight 
become constant21,22. The percentage inhibition of the 
wet weight and dry weight of the granuloma were 
calculated. The percent inhibition increase in the 
weight of the cotton pellets was calculated by: 
 % inhibition = Wc–  WtWc ⨯ 100 
 
Where Wc is granulation weight in the control 
group and Wt is the granulation weight in the treated 
group 
All the values were expressed as Mean±S.E.M. the 
results were analyzed statistically by one-way 
ANOVA followed by Dunnett Multiple comparison 
test, P <0.001 was considered significant. 
 
Results and Discussion 
The preliminary phytochemical analysis of ethyl 
acetate extract of C. punctatum var. squamosum 
revealed the presence of flavonoids and steroids as 
shown in Table 1, which may be liable to contribute 
toward the biological activities of the plant. 
After performing acute toxicity test using OECD 
425 guidelines, the ethyl acetate extracts of leaves  
of C. punctatum, even at a high dose of  
2000 mg/kg b.w., did not cause any untoward 
symptomatic behavior in the test animals as seen  
in Table No 2. 
The biological membrane contains polyunsaturated 
lipid which is prone to the oxidative reaction of free 
radicals, which leads to lipid peroxidation. The lipid 
peroxidation products like malondialdehyde (MDA), 
4-hydroxyl 2-nonenal (4-HNE), and some other 
alkanes form adducts with significant irreversible 
effects on cellular functions and biochemistry when 
they react with cell macromolecules23,24. The 
formation of adducts thus leads to membrane 
permeability, oxidative nucleic acid damage, and 
eventually to mutation and cancer25,26. In this study, 
the antioxidant activity was tested for lipid 
peroxidation inhibition. The lipid peroxidation 
inhibitory effect of the ethyl acetate extract of  
C. punctatum var. squamosum and the standard were 
shown in Table 3. The percentage inhibition of lipid 
peroxidation of the extract and the standard  
α-tocopherol at a concentration of 100 μg/mL was 
76.93 and 86.21% respectively. The EC50 value 
calculated was found to be 22.324 μg/mL for the 
standard compound and 48.23 μg/mL for the ethyl 
acetate extract. 
DPPH radical is one of the free radicals widely 
used for testing preliminary radical scavenging 
activity of the plant extract27. The results of DPPH 
radical scavenging activity of ethyl acetate extract of 
C. punctatum var. squamosum and the standard were 
shown in Table 4. In this study, the extract 
 
Table 2 — Observations for the presence of symptomatic behaviour in acute toxicity study of ethyl acetate extract of  
C. punctatum var. squamosum 
 
Treatment Tremors Convulsion Lethargy Sleep Coma Diarrhoea Salivation Mortality 
Control 
(0.3% Sodium Carboxy Methyl Cellulose) - - - - - - - - 
Ethyl acetate extract (2000 mg/kg b.w.) - - - - - - - - 
[Key: ( - ) indicates absence] 
 
 
Table 1 — Preliminary phytochemical screening of ethyl acetate 
extract of C. punctatum var. squamosum 
 
S.No. Phytochemical test Ethyl acetate extract 
1 Alkaloids -ve 
2 Glycosides -ve 
3 Tannins -ve 
4 Flavonoids +ve 
5 Steroids +ve 
6 Saponins -ve 
7 Proteins and amino acids -ve 
8 Fats and fixed oil -ve 
9 Carbohydrates -ve 
[Key: + indicates presence, - indicates absence] 
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significantly reduced the DPPH radical with 
increasing concentrations of the plant extract. This 
may indicate an increased ability to donate hydrogen 
ions which results in a lighter solution which is 
proportional to the number of electrons gained28. The 
percentage inhibition of the DPPH radical by the ethyl 
acetate extract of C. punctatum var. squamosum and 
standard BHT at 5 μg/mL was 78.9 and 79.13% 
respectively. The EC50 value for both the extract and 
BHT was calculated and found to be 1.298 μg/mL  
for the extract while it was 0.104 μg/mL for the 
standard BHT. 
Inflammation is a physiological response that 
protects the body from the injury of the tissues. 
Acute inflammation occurs very rapidly, and the 
course of action can last for few or several minutes 
to several days, with exudation of fluid and plasma 
proteins as its main features.When the acute 
inflammatory occurs repeatedly or continuously, 
chronic inflammation occurs with the process lasting 
for several weeks to months and even years29. 
Denaturation of proteins is a well-documented cause 
of inflammation in many disease conditions30. 
Proteins are denatured when exposed to stresses like 
heat, strong acid or base and results in the loss of 
their biological functions. When bovine serum 
albumin (BSA) is heated it undergoes denaturation 
and expresses antigens associated with type III 
hypersensitive reactions which are related to diseases 
such as serum sickness, glomerulonephritis, 
rheumatoid arthritis, and systemic lupus 
erythematous31. Thus, the in vitro anti-denaturation 
(stabilization) effect of heat-treated (immunogenic) 
bovine serum albumin assay is being used for 
detecting a wide range of anti-inflammatory 
compounds. NSAIDs (Non-Steroidal Anti-
inflammatory Drugs) have been widely used for 
treating inflammation. They act by inhibiting the 
production of endogenous prostaglandins and also 
preventing the denaturation of proteins32. The anti-
inflammatory effect of ethyl acetate extract of  
C. punctatum var. squamosum was observed by 
evaluating the inhibitory effect on albumin 
denaturation. Maximum inhibition of 61.63% by the 
extract was observed at 500 µg/mL. Diclofenac 
sodium, a standard anti-inflammatory drug  
showed the maximum inhibition of 90% at the 
concentration of 500 µg/mL (Table 5). The EC50 
value was found to be 361.5 µg/mL for the  
ethyl acetate extract while for the standard 
compound diclofenac sodium, it was found to be 
129.66 µg/mL. 
During inflammation, lyses of lysosome srelease 
their component enzymes which lead to a variety of 
disorders. The beneficial effects of non-steroidal 
anti-inflammatory drugs (NSAIDs) are the results 
of inhibition of the released lysosomal enzymes or 
stabilization of the lysosomal membranes33. The 
HRBC membrane stabilization has been used as a 
method to study the in vitro anti-inflammatory 
activity because the erythrocyte membrane is 
similar to that of the lysosomal membrane and its 
stabilization indicates that the extract may well 
stabilize lysosomal membranes34,35. Table 6 shows 
that the ethyl acetate extract at different 
concentration range has shown significant 
percentage inhibition of haemolysis and has 
maximum inhibition of 59% at 500 µg/mL 
compared with the standard diclofenac sodium 
 
Table 5 — Effect of ethyl acetate extract of C. punctatum var. 
squamosum on albumin denaturation 
S. No Concentration 
(µg/mL) 
% Inhibition of 
diclofenac  
(Mean) 
% Inhibition of ethyl 
acetate extracts 
(Mean) 
1 100 66.66 27.63 
2 200 80.00 31.60 
3 300 83.00 41.36 
4 400 86.66 58.56 
5 500 90.00 61.63 
 
 
Table 3 — Effect of ethyl acetate extract of C. punctatum var. 
squamosum on lipid peroxidation 
S. No Concentration 
(µg/mL) 
% Inhibition of 
standard 
α-tocopherol (Mean) 
% Inhibition of 
ethyl acetate 
extract (Mean) 
1 10 59.18 30.23 
2 20 65.67 24.70 
3 40 71.62 54.26 
4 60 77.83 61.03 
5 80 81.62 64.56 
6 100 86.21 76.93 
 
Table 4 — DPPH radical scavenging activity of ethyl acetate 
extract of C. punctatum var. squamosum 
S. No Concentration 
(µg/mL) 
% Inhibition of 
BHT (Mean) 
% Inhibition of ethyl 
acetate extract (Mean) 
1 0.1 46.26 33.50 
2 0.5 51.32 45.30 
3 1.0 58.74 57.30 
4 2.0 65.34 61.50 
5 3.0 69.61 72.10 
6 4.0 74.46 74.20 
7 5.0 79.13 78.90 
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which shows maximum inhibition of 91.66%  
at 500 µg/mL. The EC50 value for the ethyl  
acetate extract was found to be 371.2 µg/mL  
while it was 162.7 µg/mL for the standard 
compound. 
The in vivo anti-inflammatory activity was 
assessed on ethyl acetate extract of the plant at two 
different doses (200 and 400 mg b.w.) in rat models 
using cotton pellet induced granuloma and 
carrageenan-induced paw oedema. It was observed 
that the ethyl acetate extract at dose 200 mg/kg and 
400 mg/kg b.w. produced a significant anti-
inflammatory activity (P <0.001) by reducing the 
dry weight and wet weight granuloma but lower 
than the standard drug diclofenac sodium. The 
percent inhibition of granuloma formation exhibited 
by a high dose of the extract was found to be almost 
comparable with the standard drug diclofenac at a 
dose of 10 mg/kg b.w. (Table 7). A reduction in 
paw oedema induced by carrageenan was also 
observed in Table 8 for both the standard 
diclofenac sodium at a dose of 10 mg/kg b.w. and 
two different doses (200 and 400 mg/kg b.w.) of 
ethyl acetate extracts (P <0.001) when compared 
with control. It was found that the paw-oedema 
inhibition exhibited by the high dose (400 mg/kg 
b.w.) ethyl acetate extract was much higher than 
that exhibited by the standard diclofenac at a dose 
of 10 mg/kg b.w. The anti-inflammatory activity of 
the ethyl acetate extract of C. punctatum var. 
squamosum leaves, as well as the standard drug, 
was found to be dose-dependent in both the in vivo 
models. 
 
Table 6 — Effect of ethyl acetate extract of C. punctatum var. 
squamosum on HRBC membrane stabilization 
S. No Concentration 
(µg/mL) 
% Inhibitionof 
haemolysis by 
standard diclofenac 
sodium 
% Inhibition of 
haemolysis by ethyl 
acetate extract 
1 100 57.37 30.28 
2 200 69.23 36.06 
3 300 77.88 43.00 
4 400 87.50 54.57 
5 500 91.66 59.00 
 
 
Table 7 — Effect of ethyl acetate extract of C. punctatum var. squamosum on cotton pellets induced granuloma 
Groups Treatment Dose 
(mg/kg) 
Mean wet weight of 
cotton (g) 
% Inhibition in wet 
weight 
Mean dry weight (g) % Inhibition in dry 
weight 
1 Control 
(Normal saline) 
- 78.87±1.17 - 24.70±0.86 - 
2 Standard 
(Diclofenac) 
10 54.90±1.25 30.39 13.57±0.69 45.06 
3 Ethyl acetate extract 200 68.32±0.88 13.38 18.55±0.65 24.89 
4 Ethyl acetate extract 400 55.42±0.98 29.73 14.95±0.97 39.48 
Each value represents Mean±S.E.M., n=4; p value <0.001 compared with control 
 
Table 8 — Effect of ethyl acetate extract of C. punctatum var. squamosum on carrageenan-induced paw oedema 
Groups Treatment Initial paw 
thickness 
Change in paw thickness in mm (Mean±SEM) value+ % Inhibition of paw oedema 
1 h 2h 3h 4h 5h 6h 
1 Control 
(1% carrageenan + 
Normal saline) 
3.21±0.01 5.32±0.01 5.41±0.01 5.41±0.02 5.40±0.01 5.23±0.01 5.10±0.01 
2 Standard 
(1% carrageenan +  
10 mg/kg Diclofenac) 
 
3.20±0.02 4.14±0.01 
(22.18%) 
 
4.03±0.01 
(25.51%) 
3.92±0.06 
(27.54%) 
3.82±0.01 
(29.26%) 
3.67±0.01 
(29.83%) 
3.51±0.01 
(31.18%) 
3 Low dose Extract 
(1% carrageenan +  
200 mg/kg ethyl acetate 
extract) 
3.29±0.01 4.50±0.02 
(15.42%) 
 
4.05±0.26 
(25.14%) 
4.03±0.19 
(25.60%) 
3.88±0.15 
(28.24%) 
3.70±0.06 
(29.25%) 
3.65±0.05 
(28.43%) 
4 High dose Extract 
(1% carrageenan +  
400 mg/kg ethyl acetate 
extract) 
3.27±0.01 4.05±0.26 
(23.87%) 
 
3.83±0.23 
(29.30%) 
3.78±0.18 
(30.22%) 
3.425±0.10 
(36.57%) 
3.20±0.11 
(38.81%) 
3.10±0.09 
(39.22%) 
All values are expressed as Mean±SEM (n=4); P <0.001 when compared with control 
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Conclusion  
The present study demonstrated that the ethyl 
acetate extract of C. punctatum var. squamosum 
possessed significant in vitro anti-oxidant property 
when compared with standard compounds like α-
tocopherol and butylated hydroxytoluene even though 
the standard compounds were found to have better 
activities.The in vitro anti-inflammatory activity 
studies using protein denaturation and HRBC 
membrane stabilization models showed that the ethyl 
acetate extract exhibited a certain amount of anti-
inflammatory activities but not as good as the 
standard diclofenac sodium. The acute toxicity study 
of the ethyl acetate extract of C. punctatum leaves 
using OECD 425 limit test showed that it is safe to be 
used at the doses required in each in vivo test and the 
LD50 value is higher than 2000 mg/kg b.w. The in 
vivo anti-inflammatory activity study of the extract 
using cotton-pellet induced granuloma model showed 
that the ethyl acetate extract could inhibit granuloma 
formation at both 200 and 400 mg/kg b.w., but the 
standard diclofenac exhibited better anti-
inflammatory activity even at a low dose of 10 mg/kg 
b.w. However, in the in vivo acute carrageenan-
induced inflammation model, it was found that the 
ethyl acetate extract, at a dose of 400 mg/kg b.w. 
exhibited better anti-inflammatory activity than the 
standard drug at a dose of 10 mg/kg b.w. Further 
investigation is required for identifying the unknown 
bioactive compounds and to establish their 
pharmacological properties involved in the activities. 
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